As a result, in the current study, we assessed the expression of CCAT2 in breast cancer tissues with regard to the expression of its target MYC. Subsequently, we evaluated the relationships between CCAT2 and MYC expression levels in tumor tissues and the clinical prognostic characteristics of breast cancer patients. Here, CCAT2 is linked to neoplasm.